Health Care & Life Sciences » Pharmaceuticals | Cannabis Science Inc.

Cannabis Science Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
16,037.60
5,934.30
16,884.80
19,137.20
10,199.10
Depreciation, Depletion & Amortization
59.10
110.80
208.20
-
46.30
Other Funds
813.40
421.60
12.50
6.00
-
Funds from Operations
1,233.90
1,025.60
899.70
1,577.10
1,709.00
Changes in Working Capital
593.50
593.20
406.40
866.90
18.80
Net Operating Cash Flow
640.30
432.50
493.30
710.20
1,690.20
Capital Expenditures
21.40
-
-
-
-
Net Investing Cash Flow
151.70
36.70
60.20
12.50
12.50
Issuance/Reduction of Debt, Net
-
-
450.00
335.10
35.90
Net Financing Cash Flow
813.40
446.60
562.50
749.60
1,966.60
Net Change in Cash
21.40
22.60
9.10
51.90
270.90
Free Cash Flow
659.50
432.50
493.30
710.20
1,690.20
Net Assets from Acquisitions
15.80
-
10.20
-
-
Other Sources
-
50.00
-
12.50
-
Change in Capital Stock
-
25.00
1,000.00
408.50
2,002.50
Exchange Rate Effect
-
-
-
-
7.00
Other Uses
114.60
86.70
50.00
-
12.50

About Cannabis Science

View Profile
Address
19800 MacArthur Boulevard
Irvine California 92612
United States
Employees -
Website http://www.cannabisscience.com
Updated 07/08/2019
Cannabis Science, Inc. develops cannabis pharmaceutical products. The company works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. Cannabis Science was founded by Raymond C.